文献速递运动医学关节外科

肩峰下球囊间隔器植入治疗巨大不可修复肩袖撕裂后达到临床有意义改善的结果比例高:系统综述与Meta分析

High Rate of Clinically Meaningful Achievement in Outcomes After Subacromial Balloon Spacer Implantation for Massive Irreparable Rotator Cuff Tears: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Sports Med · 2023-03-22

本系统综述与Meta分析(证据等级4)纳入10项研究,评估肩峰下球囊间隔器植入治疗巨大不可修复肩袖撕裂后达到最小临床重要差异(MCID)、患者可接受症状状态(PASS)和实质性临床获益(SCB)的比例。Constant-Murley评分MCID总合并率为83%(95%CI 71%-93%),ASES评分MCID率为83%-87.5%,短中期随访显示临床显著改善比例高;定义和评估PASS与SCB的文献有限,需进一步研究。

要点

  • Constant-Murley评分MCID总合并率为83%(95%CI 71%-93%),8项研究中6项报告率≥85%。
  • ASES评分MCID率为83%-87.5%,2年PASS率为56%,1年和2年SCB率分别为83%和82%。
  • 定义和评估PASS与SCB的文献有限,需进一步研究。

核心结论

  • 接受单纯肩峰下球囊间隔器植入的巨大不可修复肩袖撕裂患者,在短至中期随访中表现出高比例的临床显著结局改善。
  • 定义和评估肩峰下球囊间隔器植入后达到PASS和SCB比例的文献有限,需进一步研究。

研究设计与样本

  • 系统综述与Meta分析,证据等级4。
  • 检索PubMed、Ovid/MEDLINE和Cochrane数据库,检索时间为2022年7月,纳入报告肩峰下球囊间隔器植入后临床显著结局的研究。
  • 采用Freeman-Tukey双反正弦变换量化MCID、PASS和SCB的合并达到率;数据呈现方式不一致时进行定性分析以避免误导性报告。
  • 共纳入10项研究,均报告MCID达到率。

主要发现

  • Constant-Murley评分MCID总合并达到率为83%(95%CI 71%-93%;范围40%-98%),8项研究中6项报告率等于或超过85%。
  • 一项研究报告Constant-Murley评分3年随访PASS达到率为98%。
  • ASES评分MCID达到率范围为83%至87.5%;ASES评分2年随访PASS达到率为56%,1年和2年随访SCB达到率分别为83%和82%。
  • 1年随访时,数字评定量表(NRS)和牛津肩关节评分(OSS)的MCID达到率分别为74%和78%;3年时NRS的MCID达到率为69%,OSS为87%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 定义和评估肩峰下球囊间隔器植入后达到PASS和SCB比例的文献有限,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subacromial balloon spacers have been introduced as a potential treatment option for patients with massive irreparable rotator cuff tears. However, it is important to comprehensively assess the clinical efficacy of this procedure in the context of an increasing amount of contemporary literature. PURPOSE: To perform a systematic review of the contemporary literature to understand the propensity for clinically meaningful improvements after subacromial balloon spacer implantation for massive irreparable rotator cuff tears. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 4. METHODS: The PubMed, Ovid/MEDLINE, and Cochrane databases were queried in July 2022 for data pertaining to studies reporting clinically significant outcomes after subacromial balloon spacer implantation. Freeman-Tukey double arcsine transformation was used to quantify the pooled rate of clinically meaningful improvements in outcomes as evaluated using the minimal clinically important difference (MCID), Patient Acceptable Symptom State (PASS), and substantial clinical benefit (SCB). Qualitative analysis was performed when data were variably presented to avoid misleading reporting. RESULTS: There were 10 studies included, all of which reported MCID achievement. The overall pooled rate of MCID achievement for the Constant-Murley score was 83% (95% CI, 71%-93%; range, 40%-98%), with 6 of 8 studies reporting rates equal to or exceeding 85%. One study reported a 98% rate of PASS achievement for the Constant-Murley score at 3-year follow-up. The rate of MCID achievement for the American Shoulder and Elbow Surgeons (ASES) score ranged between 83% and 87.5%. The rate of PASS achievement for the ASES score was 56% at 2-year follow-up, while the rate of SCB achievement for the ASES score was 83% and 82% at 1- and 2-year follow-up, respectively. At 1-year follow-up, 74% and 78% of patients achieved the MCID for the Numeric Rating Scale and Oxford Shoulder Score, respectively. At 3 years, 69% of patients achieved the MCID for the Numeric Rating Scale and 87% achieved it for the Oxford Shoulder Score. CONCLUSION: Patients who underwent isolated subacromial balloon spacer implantation for massive irreparable rotator cuff tears demonstrated a high rate of clinically significant improvement in outcomes at short- to mid-term follow-up. A paucity of literature exists to appropriately define and evaluate the rates of achieving the PASS and SCB after subacromial balloon spacer implantation, necessitating further study.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kunze KN, Moran J, Cecere R, et al. High Rate of Clinically Meaningful Achievement in Outcomes After Subacromial Balloon Spacer Implantation for Massive Irreparable Rotator Cuff Tears: A Systematic Review and Meta-analysis. Am J Sports Med. 2023. PMID: 36946876. doi:10.1177/03635465231155916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。